Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05700344
What this trial is testing

SOGUG-AVELUMAB_RWD

Who this might be right for
Metastatic Urothelial Carcinoma
Spanish Oncology Genito-Urinary Group 125
Early research (Phase 1)Study completedNCT01844947
What this trial is testing

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 22
Not applicableStudy completedNCT03988309
What this trial is testing

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Who this might be right for
HematuriaUrothelial Carcinoma
Pacific Edge Limited 554
Early research (Phase 1)Study completedNCT04452214
What this trial is testing

The Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungUrothelial CarcinomaMalignant Melanoma+1 more
Cantargia AB 19
Testing effectiveness (Phase 2)UnknownNCT05895864
What this trial is testing

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 34
Not applicableLooking for participantsNCT07441499
What this trial is testing

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma (UC)Bladder (Urothelial, Transitional Cell) CancerLiquid Biopsy
Tianjin Medical University Second Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT05312671
What this trial is testing

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Who this might be right for
Small Cell Neuroendocrine Carcinoma of BladderBladder CancerUrothelial Carcinoma Bladder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Early research (Phase 1)Looking for participantsNCT06293898
What this trial is testing

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Who this might be right for
Endometrial CancerCervical CancerOvarian Cancer+7 more
SystImmune Inc. 280
Very early researchActive Not RecruitingNCT03837821
What this trial is testing

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Who this might be right for
Bladder Cancer
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Study completedNCT03464734
What this trial is testing

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 70
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Large-scale testing (Phase 3)Study completedNCT03361865
What this trial is testing

Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 93
Testing effectiveness (Phase 2)WithdrawnNCT05687721
What this trial is testing

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Who this might be right for
Advanced Urothelial Carcinoma
VA Office of Research and Development
Not applicableUnknownNCT04339933
What this trial is testing

Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Ho Kyung Seo 92
Not applicableEnded earlyNCT02027649
What this trial is testing

Detection of K14 in Bladder Cancer With a Non Invasive Technique

Who this might be right for
Bladder Cancer
Corporacion Parc Tauli 400
Testing effectiveness (Phase 2)Ended earlyNCT02316548
What this trial is testing

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Who this might be right for
Stage III Bladder CancerStage IV Bladder Cancer
NRG Oncology 14
Not applicableUnknownNCT04718948
What this trial is testing

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Who this might be right for
Urothelial CarcinomaUrinary Bladder CancerUrinary Tract Cancer
University of Florence 500
Testing effectiveness (Phase 2)Study completedNCT00003129
What this trial is testing

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Eastern Cooperative Oncology Group 75
Testing effectiveness (Phase 2)Ended earlyNCT00127595
What this trial is testing

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

Who this might be right for
Carcinoma, Transitional Cell
Gustave Roussy, Cancer Campus, Grand Paris 28
Next Page